“…Indeed, through recent improvements in digital PET camera technologies, it is now also possible to quantitatively analyze the FDG uptake in the LA. 5 Although a few prior studies have described increased atrial FDG uptake in patients with AF, 6 , 7 , 8 , 9 , 10 this was not done under standardized metabolic conditions, which is critical, because glucose uptake is not only dependent on the rate of glucose use of the heart, but also on substrate availability. Oral administration of a nicotinic acid derivative (acipimox) inhibits peripheral lipolysis decreasing plasma levels of free fatty acids and stimulates preferential glucose use by cardiac myocytes.…”